Avai Bio (AVAI) Equity Ratio (2018 - 2025)
Avai Bio's Equity Ratio history spans 7 years, with the latest figure at 4.55 for Q1 2024.
- On a quarterly basis, Equity Ratio fell 73.66% to 4.55 in Q1 2024 year-over-year; TTM through Mar 2024 was 4.55, a 73.66% decrease, with the full-year FY2024 number at 4.55, down 73.66% from a year prior.
- Equity Ratio hit 4.55 in Q1 2024 for Avai Bio, up from 4.81 in the prior quarter.
- Over the last five years, Equity Ratio for AVAI hit a ceiling of 0.09 in Q3 2020 and a floor of 4.81 in Q4 2023.
- Historically, Equity Ratio has averaged 1.81 across 5 years, with a median of 1.19 in 2022.
- Biggest five-year swings in Equity Ratio: skyrocketed 100.38% in 2020 and later tumbled 346.99% in 2021.
- Tracing AVAI's Equity Ratio over 5 years: stood at 0.53 in 2020, then increased by 23.86% to 0.4 in 2021, then tumbled by 372.1% to 1.89 in 2022, then plummeted by 154.01% to 4.81 in 2023, then increased by 5.31% to 4.55 in 2024.
- Business Quant data shows Equity Ratio for AVAI at 4.55 in Q1 2024, 4.81 in Q4 2023, and 3.74 in Q3 2023.